Skip to main content

Advertisement

Table 1 Baseline characteristics of hematologic oncology and subgroup of HCT patients

From: Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration

Variables All hematologic oncology patients (n = 401) HCT patients (n = 145)
Age, years, mean (SD) 61.6 (15.3) 53.1 (14.3)
Male, n (%) 254 (63.3) 88 (60.7)
Hematologic diagnosis
 Leukemia 157 (39.2) 82 (56.6)
 Lymphoma 131 (32.7) 35 (24.1)
 Multiple myeloma 60 (14.7) 10 (6.9)
 Other 53 (13.2) 18 (12.4)
Admission source, n (%)
 Home 341 (85.0) 123 (84.8)
 Acute care facility transfer 21 (5.2) 11 (7.6)
 Long-term care facility transfer 31 (7.7) 9 (6.2)
 Other 8 (2.0) 2 (1.4)
Comorbidities, n (%)
 Congestive heart failure 43 (10.7) 6 (4.1)
 Arrhythmia 66 (16.5) 28 (19.3)
 Valvular disease 5 (1.2) 2 (1.4)
 Peripheral vascular disease 2 (0.5) 1 (0.7)
 Hypertension 80 (20.0) 23 (15.9)
 Chronic obstructive pulmonary disease 30 (7.5) 8 (5.5)
 Diabetes mellitus 129 (32.2) 45 (31.0)
 Renal failure 26 (6.5) 4 (2.8)
 Liver disease 17 (4.2) 10 (6.9)
 Metastatic cancer 15 (3.7) 6 (4.1)
Elixhauser comorbidity score, mean (SD) 9.6 (8.2) 7.7 (6.6)
Emergency department visits in past year, median (IQR) 1 (0–2) 0 (0–1)
Hospital admissions in the past year, median (IQR) 1 (0–2) 1 (0–3)
ICU admissions in the past year, median (IQR) 0 (0–0) 0 (0–0)
Limits of care, n (%)
 Full care 300 (74.8) 126 (86.9)
 ICU-level care, no CPR 22 (5.5) 4 (2.8)
 Do not resuscitate 56 (14.0) 6 (4.1)
 Other/unknown 23 (5.7) 9 (6.2)
  1. Abbreviations: RRS rapid response system, SD standard deviation, IQR interquartile range, ICU intensive care unit, CPR cardiopulmonary resuscitation